Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of Fexuclue (DWP14012) in Non-Erosive Gastroesophageal Reflux Disease
NCT03811080Phase 3Unknown
- Sponsor
- Daewoong Pharmaceutical
- Start
- Feb 2019
- Primary completion
- Feb 2020
- Countries
- 1
01
Overview
A Phase 3 trial of fexuprazan in Non-erosive Gastroesophageal Reflux Disease (NERD), sponsored by Daewoong Pharmaceutical. Status: unknown.
02
Drugs
fexuprazan
03
Conditions
Non-erosive Gastroesophageal Reflux Disease (NERD)
Beyond the preview
Go deeper on NCT03811080.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03811080.